Introduction
Micro-RNAs (miRNAs) are a class of small endogenous non-coding RNAs that bind their target gene through perfect or imperfect base-pair complementarity. The first miRNAs discovered in Caenorhabditis elegans by Victor Ambros and Gary Ruvkun [1] were Lin-4 and let-7. Lin-4 negatively regulates the level of LIN-14 protein by imperfect complementary base pairing with the 3'UTR of the Lin-14 mRNA. Also, Lin-4 controls the timing of the development of the first larval stage [2] , and post-translational inhibition by miRNA was considered to be specific for nematodes. Surprisingly, let-7 is not limited to C. elegans, rather has been highly conserved through evolution in a range of animal species, including vertebrates, invertebrates and humans [3] [4] [5] [6] . These findings suggest that miRNAs are present and functional in a variety of organisms.
stranded RNA duplexes. The mature miRNAs are retained in the RNA-induced silencing complex (RISC) and bind to the 3'-untranslated region (UTR) of target mRNAs to regulate expression. Subsequently, miRNAs regulate mRNA expression by inducing degradation or translational repression [1] [2] [3] [4] [5] [6] [7] [8] .
Interestingly, the involvement of miRNAs in diverse physiological and pathological aspects has been revealed. For instance, miR-21 functions as an oncogene by regulating many tumor suppressor genes and is upregulated in many human malignancies [9, 10] , including breast cancer [11, 12] , glioblastoma [13] , hepatocellular carcinoma [14] , cholangiocarcinoma [15] , lung cancer [16] , tongue squamous cell carcinoma [17] , gastric cancer [18, 19] , colorectal cancer [20, 21] , and prostate cancer [22] . Moreover, evidence is accumulating that many age-related diseases are also associated with impaired cell signaling cascades. The miRNA control systems linked with the cell cycle, DNA repair, oxidative stress responses and apoptosis are abnormally expressed in midlife [23, 24] . Two heart-specific miRNAs were deleted in a large proportion of offspring mouse models, which resulted in abnormal heart development [25] . While these lethal effects were expected, another study suggested a subtler role for miRNA in the heart. When miR-208 was eliminated, the mice appeared normal; however, defects were revealed when their hearts were stressed [25, 26] . These results suggest that miRNA studies should be extended to the diagnosis of heart disease. Numerous reports have demonstrated the role of miRNAs in neural development. Evidence for the role of miRNA in Parkinson's disease comes from animal models indicated that loss of miRNAs may be involved in disease development and progression [27, 28] . In cell culture, transfer of small RNA fragments preserved the loss of function in certain miRNA-deficient nerve cells [29, 30] . While these and other results supported an important role for miRNA in neurodegenerative disorders, further work is needed to delineate the exact role of miRNAs in this important area. Recent miRNA deletion studies have revealed a central role in the regulation of the immune response. The deletion of miRNA-155 impaired T and B cell differentiation in germinal centers, and greatly decreased antibody and cytokine production. miRNA-181 and -223 were found to control the T-cell response and granulocyte production, respectively. As more roles for miRNAs in the immune response are found, the list of immune function disorders with a miRNA component will also increase [31-33].
The miRNAs can be transmitted from one species to another, which can result in cross-species regulation of gene expression. Many evidences suggest that food-derived exogenous miRNAs exist in blood and organs of mammals, where they serve functions similar to endogenous miRNAs and simultaneously regulate either multiple target genes or biological processes [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] . Thus endogenous miRNAs of one species may influence the biologic functions of another, distantly related species (Figure 1 ). [65] [66] [67] . Such vesicles may allow miRNAs to tolerate degradation in the gastrointestinal tract and be absorbed in the intestine. These coated and/or protected miRNAs could resist the food manufacturing process and be absorbed into the intestine.
Plant miRNAs
MiRNA-containing foods are found in animals and plant resources [68, 69] [34, 72] . First, some of the plant miRNAs in human serum are genuine plant miRNAs. Also, they were detected in MVs. Second, plant miRNAs were stable in cooked food and could pass through the mouse GI tract. Third, an exogenous plant miRNA, miR-168a, binds to mammalian Ingested miRNAs accumulate in human or animal serum and regulate target gene expression in a sequence-specific manner. In other words, miRNAs in food, including colostrum, mature milk and plants, have a cross-species regulation capability.
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low-density lipoprotein receptor adapter 1 (LDLRAP1) and decreases the LDLRAP1 protein level. Indeed, the addition of mammalian miR-150 to mice feed downregulated hepatic c-Myb expression of the fed mice. Plant-derived miRNAs (e.g., rice and bean) are stable during food processing, cooking and early digestion (up to 75 min). In contrast, synthetic miRNAs were unstable under identical condition [70] . These findings suggested that vesicles, such as exosome and MVs, can also play a key role in protecting exogenous miRNAs against cooking, food processing and digestion and facilitating their delivery to their target gene. Miravirsen, the First miRNA-targeted Antiviral Drug in Phase 3 Trials miR-122, known as a hepatitis C virus (HCV)-specific miRNA, is highly expressed in the liver and plays an important role in HCV infection [73] [74] [75] [76] [77] . Especially, miR-122 binds to the 5′ untranslated region (5'UTR) of the HCV genome, unlike other miRNA which usually binds to 3' untranslated region of target mRNAs. Then, miR-122 forms an oligomeric miR-122-HCV complex, which not only protects the HCV genome from nucleotide degradation and/or host innate immune responses, but also leads to upregulation of HCV replication in infected liver cells [73] [74] [75] [76] [77] . Miravirsen (SPC3649) is a chemically modified anti-miR oligonucleotide and the first anti-miR drug candidate for treatment of HCV infection, which targets miR-122. Locked nucleic acids (LNAs) is a bicyclic RNAs in which the ribose ring is locked by introduction of a 2'-O, 4'-C methylene bridge, resulting the antisense-oligonucleotides (ASOs) showing a high affinity for the target site [78, 79] . Clinical safety and efficacy testing of miravirsen in a phase 2a clinical study has been completed [80] . Miravirsen resulted in a dose-dependent reduction in HCV RNA levels in 36 patients receiving 3, 5, and 7 mg per kg body weight, with the exception of one patient in the 5 mg group and four patients in the 7 mg group. Five patients in the miravirsen groups had side effects of moderate severity, including headache, otitis externa, pelvic bone injury after a fall, syncope and flulike symptoms. Studied of miravirsen have not indicated side effect in animals [80, 81] . However, the only serious side effect was loss of consciousness in one patient [82] . Exogenous and even chemically modified miRNAs can exert a prolonged anti-viral effect. Dangerous side effects that can occur due to the multi-targeting ability of miRNA did not occur except for one patient in the clinical trial. Miravirsen is now preparing a phase 3 clinical trial. Therefore, based on the targeting of miR-122 with miravirsen, design of functional foods containing miRNA antisense or mimic oligonucleotide seems feasible.
Cross-Kingdom Activity of miRNAs

Micro-RNAs in Nutrition Act as Epigenetic Regulators
Nutritional epigenetics can modify physiologic processes through epigenetic regulation of gene expression [46] [47] [48] .
Various nutrients-such as vitamins, methionine, choline, folate, and betaine-can affect DNA modification, and bioactive compounds-including vitamins, fatty acids, curcumin and resveratrol-can regulate the expression of miRNAs [8, 48, 83, 84] . These recent findings suggested that nutrients and bio-compounds in food either directly participate in gene regulation or indirectly affect post-transcriptional regulation by regulating miRNA expression. The nutrients and/or biochemicals that regulate miRNA expression are summarized in Table 1 . Although research on the relationship between food and miRNA gene expression or regulation is limited, it will be worthy to check the possibility of synergic effect through the combination of meaningful miRNAs as an ingredient of food for human health. miRNAs are specifically up-and/or down expressed in various disease states, research into use of miRNAs as biomarkers or therapeutics is underway. However, there is little interest in use of miRNA in food or animal feed, due to issues such as absorption, degradation during food processing or digestion, and side effects (Figure 2 ). In this review of dietary miRNA, such as plant miRNAs and milk miRNAs, we confirmed the possibility of their application in food or animal feed. miRNAs stable under harsh conditions (pH 1, RNase, 37 °C) which is associated with their packaging into vesicles, including exosomes and MVs. Conde et al. reported that self-assembled RNA-triple-helix conjugates remain functional in vitro and in vivo, and that they induce 90% tumor shrinkage in a triplenegative breast cancer mouse model [85] . An RNA-triplehelix structure is created by two miRNAs, an miRNA mimic (tumor suppressor miRNA) and an antagomiR (oncomiR inhibitor). This is a new means of improving the stability of exogenous miRNAs in mammalian systems. In addition, ingested miRNAs can regulate human gene expression. The greatest obstacles in clinical miRNA research are unexpected side effects due to the multi-targeting ability of miRNAs. The phase 2 clinical study of miravirsen, the first miRNA inhibitor drug candidate, reported no serious side effects except for one case and there was no adverse effect in animal testing. A negative or positive relationship between miRNA and nutrients would be an important factor for their use in food or animal feed. As found additional role of nutrients on the indirectly inhibition of the gene via the miRNA, synergic effect between nutrients and dietary miRNA would be also possible. The relationship between foods and miRNAs is highly associated at the epigenetics mechanistic support. Therefore, miRNAs or ASO and/or mimic of miRNAs associated with specific disease enable exogenous control in the body. The high-tech level functional food can be achieved by combining several core mi-RNAs mimics or antisense oligonucleotides that can selectively suppress target gene expression under physiologic conditions. Core miRNAs involved in various processes such as physical exercise [86, 87] , cough prevention or release [88] , obesity [89, 90] , and cancer prevention [8] would be effective resource for food or animal feed. We can apply not only mimics of the core miRNAs as tumor suppress gene but also ASO of core miRNAs as oncogene with combination strategy. Packaging of artificial ASO and/or miRNA mimics within exosomes maintains their stability during digestion. MiRNA-containing foods are absorbed in the intestine and the miRNAs delivered to the bloodstream. Endocytosis of the exosome results in delivery of miRNAs and regulation of the expression of their target genes.
Conclusion and Perspectives
Use of miRNAs in food may be an effective method of disease prevention by synergic combination of miRNA modulation and phytochemicals. For example, miRNA mimics that suppress expression of cancer-causing genes are packaged in vesicles, and biologically meaningful amounts of packaged miRNAs can be added to food. Use of such combinations of common miRNAs will facilitate development. 
Upregulated miRNAs Downregulated miRNAs References
Vitamin A let-7a-3, let-7c, let-7d, miR-15a, miR-15b, miR- Oleic acid miR-21
DIM, 3',3'-diindolylmethane; SCFA butyrate, short chain fatty acid butyrate miRNA-containing biomaterials (ASO or mimics) may be useful function food ingredients to prevent and treat various diseases.
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